Printer Friendly
The Free Library
14,506,104 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Solvay Pharmaceuticals, Inc. Acquires North American Marketing Rights for Anoheal and Incostop from SLA Pharma AG.


Business Editors & Health Writers

MARIETTA, Ga.--(BUSINESS WIRE)--Jan. 14, 2002

Solvay Pharmaceuticals, Inc. and SLA (1) (StereoLithography Apparatus) See 3D printing.

(2) (Service Level Agreement) A contract between the provider and the user that specifies the level of service expected during its term.
 Pharma AG today announced they have entered into an agreement by which Solvay Pharmaceuticals acquires the North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 marketing rights for Anoheal(R) and Incostop(R) from SLA Pharma of Switzerland and the United Kingdom.

Financial details of the agreement were not disclosed.

Anoheal(R) is a topical cream in phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA  development for the treatment of anal fissures. Clinical studies seek to support both a pain and healing indication for this product. Also in phase III development, Incostop(R) is in development as a topical gel for the treatment of fecal incontinence Fecal Incontinence Definition

Fecal incontinence is the inability to control the passage of gas or stools (feces) through the anus. For some people fecal incontinence is a relatively minor problem, as when it is limited to a slight occasional soiling of
. There are currently no other products on the market for these conditions.

Under the terms of the agreement, Solvay Pharmaceuticals is responsible for all commercialization efforts in North America, while SLA Pharma is responsible for the design and conduct of clinical studies and regulatory filing, as well as support of the marketing applications for both products.

"This agreement between Solvay Pharmaceuticals and SLA Pharma greatly enhances the value of Solvay Pharmaceuticals' gastroenterology gastroenterology

Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833.
 franchise and tangibly demonstrates our strategic commitment to serving the needs of the specialty gastroenterology communities," said Solvay Pharmaceuticals, Inc. President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Harold H. Shlevin. "Solvay Pharmaceuticals has established relationships with key gastroenterologists and other specialty physicians whose patients are expected to derive significant therapeutic and quality of life benefits from these products."

"This licensing agreement will enable the product to be successfully marketed by a company who already has a good relationship with the target audience," said SLA Pharma CEO Justin Slagel.

About Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc. (www.solvaypharmaceuticals-us.com) of Marietta, Georgia, is a research-based pharmaceuticals company, active in the therapeutic areas of cardiology, gastroenterology, mental health and women's health Women's Health Definition

Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
. It is a member of the worldwide Solvay S.A. chemical and pharmaceutical group, headquartered in Brussels, Belgium.

The Solvay Group employs about 32,000 people in 50 countries. In 2000 its consolidated sales amounted to EUR EUR

In currencies, this is the abbreviation for the Euro.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 8.9 billion generated by its four activity sectors: Pharmaceuticals, Chemicals, Plastics and Processing. Solvay is listed in the Euronext 100 index of top European companies.

About SLA Pharma

SLA Pharma (www.slapharma.com)based in Switzerland and the United Kingdom, is a pharmaceutical company with expertise in developing pharmaceutical products for use in the management of anorectal a·no·rec·tal
adj.
Relating to the anus and the rectum.



anorectal

pertaining to, emanating from or affecting the anorectum.


anorectal abscess
see perianal fistula.
, gastrointestinal and urinary diseases. The Company has access to centers of scientific expertise in this area, and the management team has proven experience in developing pharmaceutical products in these related indications.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 14, 2002
Words:422
Previous Article:Network Engines to Webcast Discussion of First Quarter Results.
Next Article:Haber Inc. Announces HGP Gold Mining License Agreement in Germany and the Addition of Key People to the Company; A Growing List of Countries are...
Topics:



Related Articles
SCHWARZ PHARMA ACQUIRES RIGHTS TO DRUG FOR EPILEPSY.(Brief Article)
Teva and Aventis Pharmaceuticals Agree to Make Teva Marion Partners a Subsidiary of Teva.
Schwarz Pharma's Rights to Growth Hormone Products Reacquired by Genentech; Schwarz Pharma to Focus on Central Nervous System and Urology.
15 European Countries Agree to Approve Copaxone, Announces Teva Pharmaceutical and Aventis Pharma; Initial Launches Scheduled for Fourth Quarter 2001.
Noven Board of Directors Adopts Stockholder Rights Plan.
Aventis Pharmaceuticals Expands Virtual Detailing to Enhance Direct-to-Physician Communications.
Biovail Acquires Teveten and Teveten HCT U.S. Marketing Rights From Solvay Pharmaceuticals Marketing and Licensing AG.
METACORE PROVIDES MANUALLY CURATED HUMAN DATA BY PHD'S.
Takeda Pharmaceutical to Establish New Sales and Marketing Company in London.
Solvay America, Inc.(People in the Industry)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles